Vanguard Group
SFE

Vanguard Group’s Safeguard Scientifics, Inc. SFE Stock Holding History

Vanguard Group’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-661,144
Closed -$519K – 4545
2023
Q4 		$519K Sell
661,144
-31,779
-5% -$32K ﹤0.01% 4025
2023
Q3 		$693K Hold
692,923
– – ﹤0.01% 3957
2023
Q2 		$1.14M Hold
692,923
– – ﹤0.01% 3859
2023
Q1 		$1.19M Hold
692,923
– – ﹤0.01% 3865
2022
Q4 		$2.15M Buy
692,923
+46,767
+7% +$157K ﹤0.01% 3631
2022
Q3 		$2.41M Hold
646,156
– – ﹤0.01% 3674
2022
Q2 		$2.41M Hold
646,156
– – ﹤0.01% 3729
2022
Q1 		$3.37M Sell
646,156
-5,854
-0.9% -$35.4K ﹤0.01% 3716
2021
Q4 		$4.79M Sell
652,010
-364,579
-36% -$2.85M ﹤0.01% 3638
2021
Q3 		$9.03M Buy
1,016,589
+40,829
+4% +$327K ﹤0.01% 3300
2021
Q2 		$7.57M Sell
975,760
-253,925
-21% -$1.73M ﹤0.01% 3356
2021
Q1 		$8.39M Buy
1,229,685
+202,381
+20% +$1.47M ﹤0.01% 3245
2020
Q4 		$6.55M Sell
1,027,304
-396,254
-28% -$2.47M ﹤0.01% 3215
2020
Q3 		$7.8M Sell
1,423,558
-53,486
-4% -$319K ﹤0.01% 2913
2020
Q2 		$10.3M Sell
1,477,044
-62,912
-4% -$398K ﹤0.01% 2754
2020
Q1 		$8.55M Buy
1,539,956
+41,094
+3% +$367K ﹤0.01% 2688
2019
Q4 		$16.5M Buy
1,498,862
+267,139
+22% +$3.05M ﹤0.01% 2624
2019
Q3 		$14M Sell
1,231,723
-59,616
-5% -$710K ﹤0.01% 2650
2019
Q2 		$15.6M Buy
1,291,339
+153,584
+13% +$1.8M ﹤0.01% 2641
2019
Q1 		$12.3M Buy
1,137,755
+3,952
+0.3% +$40.1K ﹤0.01% 2715
2018
Q4 		$9.77M Sell
1,133,803
-79,383
-7% -$692K ﹤0.01% 2786
2018
Q3 		$11.3M Sell
1,213,186
-56,802
-4% -$617K ﹤0.01% 2853
2018
Q2 		$16.3M Buy
1,269,988
+292,168
+30% +$3.77M ﹤0.01% 2663
2018
Q1 		$12M Buy
977,820
+66,476
+7% +$808K ﹤0.01% 2738
2017
Q4 		$10.2M Sell
911,344
-21,289
-2% -$273K ﹤0.01% 2805
2017
Q3 		$12.4M Buy
932,633
+112,940
+14% +$1.39M ﹤0.01% 2708
2017
Q2 		$9.75M Sell
819,693
-9,204
-1% -$108K ﹤0.01% 2786
2017
Q1 		$10.5M Buy
828,897
+15,086
+2% +$190K ﹤0.01% 2741
2016
Q4 		$10.9M Buy
813,811
+11,521
+1% +$142K ﹤0.01% 2705
2016
Q3 		$10.4M Buy
802,290
+5,333
+0.7% +$70.7K ﹤0.01% 2669
2016
Q2 		$9.95M Buy
796,957
+9,856
+1% +$132K ﹤0.01% 2651
2016
Q1 		$10.4M Buy
787,101
+41,328
+6% +$520K ﹤0.01% 2590
2015
Q4 		$10.8M Buy
745,773
+8,495
+1% +$137K ﹤0.01% 2593
2015
Q3 		$11.5M Buy
737,278
+6,938
+0.9% +$125K ﹤0.01% 2542
2015
Q2 		$14.2M Buy
730,340
+8,578
+1% +$157K ﹤0.01% 2502
2015
Q1 		$13.1M Buy
721,762
+12,582
+2% +$233K ﹤0.01% 2511
2014
Q4 		$14.1M Buy
709,180
+6,373
+0.9% +$123K ﹤0.01% 2400
2014
Q3 		$12.9M Buy
702,807
+9,644
+1% +$190K ﹤0.01% 2382
2014
Q2 		$14.4M Buy
693,163
+1,994
+0.3% +$40.1K ﹤0.01% 2351
2014
Q1 		$15.3M Buy
691,169
+47,168
+7% +$937K ﹤0.01% 2290
2013
Q4 		$12.9M Buy
644,001
+12,060
+2% +$213K ﹤0.01% 2340
2013
Q3 		$9.91M Buy
631,941
+23,769
+4% +$366K ﹤0.01% 2400
2013
Q2 		$9.76M Buy
+608,172
New +$9.67M ﹤0.01% 2340

Other funds holding SFE

CP
Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
FWM
FSA Wealth Management Needham, Massachusetts $273M AUM 16.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vanguard Group's SFE Position: Q1 2024 in Review

Vanguard Group sold out of Safeguard Scientifics, Inc. (SFE) in Q1 2024, closing a stake of 661,144 shares — an estimated $519K sold.

Vanguard Group first reported a position in SFE in Q2 2013 and held it in 43 quarters. The position peaked at $16.5M in Q4 2019. 4 funds tracked by Wall St. Rank hold SFE as of Q1 2024.

  • Vanguard Group reported no remaining Safeguard Scientifics, Inc. position as of Q1 2024 after selling out during the quarter.
  • Vanguard Group sold 661,144 Safeguard Scientifics, Inc. shares in Q1 2024, an estimated $519K.
  • Vanguard Group first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 43 quarters.
  • Vanguard Group's Safeguard Scientifics, Inc. position peaked at $16.5M in Q4 2019.
  • 4 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.